Tailoring dry powder inhaler performance by modifying carrier surface topography by spray drying

Atomization and Sprays

Volumn 20, Issue 9, 2010, Pages 763-774

  Maas, Stephan G ^a   Schaldach, Gerhard ^b   Walzel, Peter E ^b   Urbanetz, Nora A ^c  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b TU DORTMUND UNIVERSITY   (Germany)

^c GRAZ UNIVERSITY OF TECHNOLOGY   (Austria)

Author keywords

Dosing; Dry powder inhaler; Fine particle fraction; Mannitol; Spray drying; Surface

Indexed keywords

ASSOCIATION REACTIONS; DRYING; PARTICLE INTERACTIONS; POLYOLS; SPRAY DRYING; SURFACE ROUGHNESS; SURFACES; TEMPERATURE; TOPOGRAPHY;

ACTIVE INGREDIENTS; CARRIER PARTICLES; DOSING; DRY POWDER INHALER; FINE PARTICLE FRACTIONS; INTER-PARTICLE INTERACTION; MANNITOL; OUTLET TEMPERATURE;

SURFACE TOPOGRAPHY;

EID: 79251582512     PISSN: 10445110     EISSN: None     Source Type: Journal    
DOI: 10.1615/AtomizSpr.v20.i9.20     Document Type: Article

References (58)

1. Adi, H., Larson, I., Chiou, H., Young, P., Traini, D., and Stewart, P., Agglomerate strength and dispersion of salmeterol xi-nafoate from powder mixtures for inhalation, Pharm. Res, vol. 23, pp. 2556-2565 2006.
2. Adi, H., Larson, I., and Stewart, P. J., Adhesion and redistribution of salmeterol xinafoate particles in sugar-based mixtures for inhalation, Int. J. Pharm., vol. 337, pp. 229-238, 2007.
3. Buckton, G., Yonemochi, E., Hammond, J., and Moffat, A., The use of near infra-red spectroscopy to detect changes in the form of amorphous and crystalline lactose, Int. J. Pharm, 168, pp. 231-241, 1998.
4. Cazzola, M., Donner, C. F., and Hanania, N. A., One hundred years of chronic obstructive pulmonary disease (COPD), Resp. Med, vol. 101, pp. 1049-1065, 2007.
5. Chan, L. W., Lim, L. T., and Heng, P. W. S., Immobilization of fine particles on lactose carrier by precision coating and its effect on the performance of dry powder formulations, J. Pharm. Sci., vol. 92, pp. 975-984, 2003.
6. Daniher, D. I. and Zhu, J., Dry powder platform for pulmonary drug delivery, Particuology, vol. 6, pp. 225-238, 2008.
7. Danjo, K., Kinoshita, K., Kitagawa, K., Iida, K., Sunada, H., and Otsuka, A., Effect of particle-shape on the compaction and flow properties of powders, Chem. Pharm. Bull., vol. 37, pp. 3070-3073, 1989.
8. Dickhoff, B. H. J., de Boer, A. H., Lambregts, D., and Frijlink, H. W., The effect of carrier surface treatment on drug particle detachment from crystalline carriers in adhesive mixtures for inhalation, Int. J. Pharm., vol. 327, pp. 17-25, 2006.
9. El-Sabawi, D., Edge, S., Price, R., and Young, P. M., Continued investigation into the influence of loaded dose on the performance of dry powder inhalers: Surface smoothing effects, Drug Dev. Ind. Pharm., vol. 32, pp. 1135-1138, 2006a.
10. El-Sabawi, D., Price, R., Edge, S., and Young, P. M., Novel temperature controlled surface dissolution of excipient particles for carrier based dry powder inhaler formulations, Drug Dev. Ind. Pharm, vol. 32, pp. 243-251, 2006b.
11. Ferrari, F., Cocconi, D., Bettini, R., Giordano, F., Santi, P., Tobyn, M., Price, R., Young, P., Caramella, C., and Colombo, P., The surface roughness of lactose particles can be modulated by wet-smoothing using a high-shear mixer, AAPS Pharmscitech, vol. 5, no. 4, pp. 1-6, 2004.
12. Fuller, K. N. G. and Tabor, D., Effect of surface-roughness on adhesion of elastic solids, Proc. R. Soc. London Ser. A, vol. 345, pp. 327-342, 1975.
13. Guchardi, R., Frei, M., John, E., and Kaerger, J. S., Influence of fine lactose and magnesium stearate on low dose dry powder inhaler formulations, Int. J. Pharm, vol. 348, pp. 10-17, 2008.
14. Hanania, N. A., Targeting airway inflammation in asthma - Current and future therapies, Chest, vol. 133, pp. 989-998, 2008.
15. Harjunen, P., Lankinen, T., Salonen, H., Lehto, V. P., and Jarvinen, K., Effects of carriers and storage of formulation on the lung deposition of a hydrophobic and hydrophilic drug from a DPI, Int. J. Pharm., vol. 263, pp. 151-163, 2003.
16. Hersey, J. A., Ordered mixing - New concept in powder mixing practice, Powder Technol, vol. 11, pp. 41-44, 1975.
17. Iida, K., Hayakawa, Y., Okamoto, H., Danjo, K., and Leuenberger, H., Evaluation of flow properties of dry powder inhalation of salbutamol sulfate with lactose carrier, Chem. Pharm. Bull, vol. 49, pp. 1326-1330, 2001.
18. Iida, K., Hayakawa, Y., Okamoto, H., Danjo, K., and Leuenberger, H., Preparation of dry powder inhalation by surface treatment of lactose carrier particles, Chem. Pharm. Bull., vol. 51, pp. 1-5, 2003a.
19. Iida, K., Hayakawa, Y., Okamoto, H., Danjo, K., and Luenberger, H., Effect of surface covering of lactose carrier particles on dry powder inhalation properties of salbutamol sulfate, Chem. Pharm. Bull., vol. 51, pp. 1455-1457, 2003b. (Pubitemid 41694772)
20. Iida, K., Hayakawa, Y., Okamoto, H., Danjo, K., and Luenberger, H., Influence of storage humidity on the in vitro inhalation properties ofsalbutamol sulfate dry powder with surface covered lactose carrier, Chem. Pharm. Bull., vol. 52, pp. 444-446, 2004a. (Pubitemid 41694731)
21. Iida, K., Inagaki, Y., Todo, H., Okamoto, H., Danjo, K., and Luenberger, H., Effects of surface processing of lactose carrier particles on dry powder inhalation properties of salbutamol sulfate, Chem. Pharm. Bull, vol. 52, pp. 938-942, 2004b. (Pubitemid 41701867)
22. Iida, K., Otsuka, A., Danjo, K., and Sunada, H., Measurement of the adhesive force between particles and a substrate by means of the impact separation method - Effect of the surface-roughness and type of material of the substrate, Chem. Pharm. Bull., vol. 41, pp. 1621-1625, 1993.
23. Iida, K., Todo, H., Okamoto, H., Danjo, K., and Leuenberger, H., Preparation of dry powder inhalation with lactose carrier particles surface-coated using a Wurster fluidized bed, Chem. Pharm. Bull., vol. 53, pp. 431-434, 2005.
24. Islam, N., Stewart, P., Larson, I., and Hartley, P., Effect of carrier size on the dispersion of salmeterol xinafoate from interactive mixtures, J. Pharm. Sci., vol. 93, pp. 1030-1038, 2004a.
25. Islam, N., Stewart, P., Larson, I., and Hartley, P., Lactose surface modification by decantation: Are drug-fine lactose ratios the key to better dispersion of salmeterol xinafoate from lactose-interactive mixtures?, Pharm. Res., vol. 21, pp. 492-499, 2004b.
26. Islam, N., Stewart, P., Larson, I., and Hartley, P., Surface roughness contribution to the adhesion force distribution of sal-meterol xinafoate on lactose carriers by atomic force microscopy, J. Pharm. Sci., vol. 94, pp. 1500-1511, 2005.
27. Labiris, N. R. and Dolovich, M. B., Pulmonary drug delivery. Part I: Physiological factors affecting therapeutic effectiveness of aerosolized medications, Br. J. Clin. Pharmacol, vol. 56, 588-599, 2003a.
28. Larhrib, H., Martin, G. P., Marriott, C., and Prime, D., The influence of carrier and drug morphology on drug delivery from dry powder formulations, Int. J. Pharm., vol. 257, pp. 283-296, 2003a.
29. Larhrib, H., Martin, G. P., Prime, D., and Marriott, C., Characterisation and deposition studies of engineered lactose crystals with potential for use as a carrier for aerosolised salbu-tamol sulfate from dry powder inhalers, Eur. J. Pharm. Sci., vol. 19, pp. 211-221, 2003b.
30. Louey, M. D., Razia, S., and Stewart, P. J., Influence of physicochemical carrier properties on the in vitro aerosol deposition from interactive mixtures, Int. J. Pharm., vol. 252, pp. 87-98, 2003.
31. Louey, M. D. and Stewart, P. J., Particle interactions involved in aerosol dispersion of ternary interactive mixtures, Pharm. Res., vol. 19, pp. 1524-1531, 2002.
32. Maas, S. G., Optimierung tragerbasierter Pulverinhalate durch Modifikation der Trageroberflache mittels Spruhtrocknung, PhD Thesis, Heinrich-Heine-Universität Düsseldorf, 2009.
33. Miller-Larsson, A. and Selroos, O., Advances in asthma and COPD treatment: Combination therapy with inhaled corticosteroids and long-acting beta(2)-agonists, Curr. Pharm. Des., vol. 12, pp. 3261-3279, 2006.
34. Mullins, M. E., Michaels, L. P., Menon, V., Locke, B., and Ranade, M. B., Effect of geometry on particle adhesion, Aerosol Sci. Technol., vol. 17, 105-118, 1992.
35. Ph. Eur., Preparations for inhalation, in European Pharmacopoeia, 6th ed., Council ofEurope, Strasbourg, pp. 739-743, 2008a.
36. Ph. Eur., Preparations for inhalation: Uniformity of delivered dose, in European Pharmacopoeia, 6th ed., Council of Europe, Strasbourg, p. 742, 2008b.
37. Ph. Eur., Preparations for inhalation: Aerodynamic assessment of fine particles, in European Pharmacopoeia, 6th ed., Council of Europe, Strasbourg, pp. 287-300, 2008c.
38. Podczeck, F., The influence of particle size distribution and surface roughness of carrier particles on the in vitro properties of dry powder inhalations, Aerosol Sci. Technol., vol. 31, pp. 301-321, 1999.
39. Podczeck, F., Newton, J. M., and James, M. B., The influence of chemical structure on the friction properties between particles and compacted powder surfaces, J. Mater. Sci., vol. 31, pp. 2213-2219, 1996.
40. Price, R. and Young, P. M., Visualization of the crystallization of lactose from the amorphous state, J. Pharm. Sci., vol. 93, pp. 155-164, 2004.
41. Rabinovich, Y. I., Adler, J. J., Ata, A., Singh, R. K., and Moudgil, B. M., Adhesion between nanoscale rough surfaces - I. Role of asperity geometry, J. Colloid Interface Sci., vol. 232, pp. 10-16, 2000.
42. Rumpf, H., Die Wissenschaft des Agglomerierens, Chem. Ing. Tech., vol. 46, pp. 1-11, 1974.
43. Saint-Lorant, G., Leterme, P., Gayot, A., and Flament, M. P., Influence of carrier on the performance of dry powder inhalers, Int. J. Pharm, vol. 334, pp. 85-91, 2007.
44. Steckel, H. and Bolzen, N., Alternative sugars as potential carriers for dry powder inhalations, Int. J. Pharm., vol. 270, pp. 297-306, 2004.
45. Steckel, H., Markefka, P., Tewierik, H., and Kammelar, R., Functionality testing of inhalation grade lactose, Eur. J. Pharm. Biopharm., vol. 57, pp. 495-505, 2004.
46. Steckel, H., Inhalationspulver- Neuere Entwicklungen bei Pulverinhalatoren, Pharm. Zeit. PZ Prisma, vol. 10, pp. 145-157, 2003.
47. Steckel, H., Markefka, P., teWierik, H., and Kammelar, R., Effect of milling and sieving on functionality of dry powder inhalation products, Int. J. Pharm, vol. 309, pp. 51-59, 2006.
48. Tabor, D., Surface forces and surface interactions, J. Colloid Interface Sci., vol. 58, pp. 2-13, 1977.
49. Tee, S. K., Marriott, C., Zeng, X. M., and Martin, G. P., The use of different sugars as fine and coarse carriers for aerosolised salbutamol sulphate, Int. J. Pharm, vol. 208, pp. 111-123, 2000.
50. Young, P. M., Cocconi, D., Colombo, P., Bettini, R., Price, R., Steele, D. F., and Tobyn, M. J., Characterization ofa surface modified dry powder inhalation carrier prepared by "particle smoothing, J. Pharm. Pharmacol, vol. 54, pp. 1339-1344, 2002.
51. Young, P. M., Roberts, D., Chiou, H., Rae, W., Chan, H.-K., and Traini, D., Composite carriers improve the aerosolisation efficiency of drugs for respiratory delivery, J. Aerosol Sci., vol. 39, pp. 82-93, 2008.
52. Zeng, X. M., Martin, G. P., Marriott, C., and Pritchard, J., The effects of carrier size and morphology on the dispersion of salbutamol sulphate after aerosolization at different flow rates, J. Pharm. Pharmacol, vol. 52, pp. 1211-1221, 2000a.
53. Zeng, X. M., Martin, G. P., Marriott, C., and Pritchard, J., The influence of carrier morphology on drug delivery by dry powder inhalers, Int. J. Pharm, vol. 200, pp. 93-106, 2000b.
54. Zeng, X. M., Martin, G. P., Marriott, C., and Pritchard, J., The influence of crystallization conditions on the morphology of lactose intended for use as a carrier for dry powder aerosols, J. Pharm. Pharmacol. , vol. 52, pp. 633-643, 2000c.
55. Zeng, X. M., Martin, G. P., Marriott, C., and Pritchard, J., Lactose as a carrier in dry powder formulations: The influence of surface characteristics on drug delivery, J. Pharm. Sci., vol. 90, pp. 1424-1434, 2001a.
56. Zeng, X. M., Martin, G. P., Marriott, C., and Pritchard, J., The use oflactose recrystallised from carbopol gels as a carrier for aerosolised salbutamol sulphate, Eur. J. Pharm. Biopharm., vol. 51, pp. 55-62, 2001b.
57. Zeng, X. M., Martin, G. P., Tee, S. K., and Marriott, C., The role of fine particle lactose on the dispersion and deaggregation of salbutamol sulphate in an air stream in vitro, Int. J. Pharm., vol. 176, pp. 99-110, 1998.
58. Zeng, X. M., Martin, G. P., Tee, S. K., bu Ghoush, A., and Marriott, C., Effects of particle size and adding sequence of fine lactose on the deposition of salbutamol sulphate from a dry powder formulation, Int. J. Pharm, vol. 182, pp. 133-144, 1999.